Picture Berlin Partner Hotspot for Startups 650x80px

News > All

Total search results: 8140 | Ordered by Date (descending)
next pagenext page 1 2 3 ... 80 81 82  next pagenext page

order ascendingorder descendingSource order ascendingorder descendingDate
Monsanto Company. (7/19/16). "Press Release: Monsanto Views Bayer’s Revised Proposal as Financially Inadequate and Insufficient to Ensure Deal Certainty". St. Louis, MO. 2016-07-19
AstraZeneca plc. (7/19/16). "Press Release: AstraZeneca Receives Approval in the EU for Qtern (saxagliptin and dapagliflozin) for Treatment of Type 2 Diabetes". 2016-07-19
Evonetix Ltd.. (7/19/16). "Press Release: One in a Billion. Cambridge Consultants Spin-out Evonetix Poised to Transform Synthetic Biology Industry". 2016-07-19
Fulcrum Therapeutics, Inc.. (7/19/16). "Press Release: Third Rock Ventures Launches Fulcrum Therapeutics with $55 Million Series A Investment". Cambridge, MA. 2016-07-19
Bicycle Therapeutics Ltd.. (7/18/16). "Press Release: Bicycle Therapeutics Appoints Stephen J. Hoffman, M.D., Ph.D., as Board Chairman". Cambridge, MA & Cambridge. 2016-07-18
T2 Biosystems, Inc.. (7/18/16). "Press Release: T2 Biosystems Announces Research and Development Collaboration with Bayer to Advance Drug Monitoring and Biomarker Discovery for Blood Coagulation Disorders". Lexington, MA. 2016-07-18
bioMérieux S.A.. (7/18/16). "Press Release: bioMérieux – Second-Quarter 2016 Business Review". Marcy l’Étoile. 2016-07-18
Merck KGaA. (7/18/16). "Press Release: Merck Relaunches Customer Collaboration Centers with New Concept and M Lab Name". Darmstadt. 2016-07-18
Euronext N.V.. (7/18/16). "Press Release: Biotech Pharnext Lists on Alternext to Pursue New Therapies for Alzheimer's. €30.9 Million Raised, Market Capitalization €100.4 Million". Paris. 2016-07-18
Merck KGaA. (7/18/16). "Press Release: Merck Receives European Medicines Agency Acceptance for Review of Marketing Authorization Application for Cladribine Tablets". Darmstadt. 2016-07-18
Roche. (7/18/16). "Press Release: Roche Provides Update on Phase III Study of Gazyva/Gazyvaro in People with Previously Untreated Diffuse Large B-cell Lymphoma". Basel. 2016-07-18
Poxel S.A.. (7/18/16). "Press Release: Poxel Closes a €26.5 Million Capital Increase". Lyon. 2016-07-18
Thermo Fisher Scientific Inc.. (7/18/16). "Press Release: New Gas Chromatography System Brings Power of Orbitrap GC-MS Technology to Routine Applications". Sunnyvale, CA. 2016-07-18
GlaxoSmithKline plc. (7/18/16). "Press Release: ARIA Study Shows Superior Efficacy of Triumeq for Treatment-naïve Women Living with HIV". London & Durban. 2016-07-18
AstraZeneca plc. (7/18/16). "Press Release: Tagrisso Met Primary Endpoint in Phase III 2nd-line Lung Cancer Trial". 2016-07-18
CellaVision AB. (7/15/16). "Press Release: Interim Report January–June 2016. A High Operating Margin and Continued Global Expansion with Strong Growth in China". 2016-07-15
Sartorius AG. (7/15/16). "Press Release: Sartorius Acquires U.S. Start-up ViroCyt". Göttingen. 2016-07-15
Merck KGaA. (7/15/16). "Press Release: Dietmar Eidens Appointed Chief HR Officer (CHRO) of Merck. Kai Beckmann Retains Executive Board Responsibility for Group Human Resources". Darmstadt. 2016-07-15
MRC Technology. (7/15/16). "Press Release: MRC Technology Monetises Royalties on Cancer Drug Keytruda (pembrolizumab) to Expand Medical Research Activities, with a Fund Managed by DRI Capital". 2016-07-15
Bayer AG. (7/14/16). "Press Release: Bayer Increases Monsanto Offer and Provides Certainty on Financing and Regulatory Matters. Monsanto All-cash Offer Increased to USD 125 per Share on July 1". Leverkusen. 2016-07-14
Boehringer Ingelheim. (7/14/16). "Press Release: Boehringer Ingelheim and University of Dundee Collaborate to Develop New Class of Medicines". Ingelheim & Dundee. 2016-07-14
F-Star Biotechnology Ltd.. (7/14/16). "Press Release: F-Star Announces Funding and Collaboration Extension with New Christian Doppler Lab for Innovative Immunotherapeutics". Cambridge. 2016-07-14
Avacta Group plc. (7/14/16). "Press Release: Avacta and Glythera Announce Collaboration to Develop Novel, Potentially Highly Potent, Drug Class". 2016-07-14
DiaSorin S.p.A.. (7/14/16). "Press Release: DiaSorin Increases Diagnostic Test Menu for Molecular Screening of Acute Myeloid Leukemia". Saluggia. 2016-07-14
Celyad S.A.. (7/14/16). "Press Release: Celyad Successfully Completes Safety Follow-up of the First Patient at the Fourth Dose Level in the NKR-2 Phase I Trial". Mont-Saint-Guibert. 2016-07-14
Sygnis AG. (7/14/16). "Press Release: Sygnis AG Successfully Completes Rights Offering and Private Placement (Ad hoc announcement according to § 15 WpHG) [Nor for US, CA, JP and AU]". Madrid & Heidelberg. 2016-07-14
Diploid. (7/14/16). "Press Release: InHelix Integrates with Face2Gene to Improve CNV analysis". Leuven. 2016-07-14
Juno Therapeutics, Inc.. (7/14/16). "Press Release: Juno Therapeutics Adds Adenosine Receptor Antagonist Through Acquisition of RedoxTherapies". Seattle, WA. 2016-07-14
Recordati Industria Chimica e Farmaceutica S.p.A.. (7/14/16). "Press Release: Recordati Acquires the Swiss Pharmaceutical Company Pro Farma". Milan. 2016-07-14
Novartis AG. (7/13/16). "Press Release: Sandoz Biosimilar Etanercept Recommended by FDA Advisory Committee for Approval to Treat Multiple Inflammatory Diseases". Holzkirchen. 2016-07-13
Boehringer Ingelheim. (7/13/16). "Press Release: Boehringer Ingelheim and Lilly Announce Clinical Trial Collaboration in Metastatic Breast Cancer". Ingelheim. 2016-07-13
Euronext N.V.. (7/13/16). "Press Release: GenSight Biologics Lists on Euronext to Become Europe's First Listed Gene Therapy Company. €40 Million Raised, Market Capitalisation €149 Million". Paris. 2016-07-13
BioRegio STERN Management GmbH. (7/13/16). "Press Release: HR News – Dr. Klaus Eichenberg Extends Contract as Managing Director of BioRegio STERN Management GmbH". Stuttgart. 2016-07-13
e-Therapeutics plc. (7/13/16). "Press Release: Board Update". Oxford. 2016-07-13
e-Therapeutics plc. (7/13/16). "Press Release: Directorate Change". Oxford. 2016-07-13
Mologen AG. (7/13/16). "Press Release: Mologen AG – First Patient Recruited in Combination Study with Lefitolimod and Yervoy. Collaboration with MD Anderson Cancer Center, US". 2016-07-13
Mologen AG. (7/13/16). "Press Release: Mologen AG – New Strategy and Major Study Milestones Achieved in First Six Months of 2016 [Not for US, AU, CA, JP, et al.]". 2016-07-13
Debiopharm S.A.. (7/13/16). "Press Release: Debiopharm Acquires a Majority Holding in the Canadian Start-up GenePOC". Lausanne. 2016-07-13
Bayer AG. (7/12/16). "Press Release: Bayer and X-Chem Expand Drug Discovery Collaboration to Discover Novel Medicines [Not intended for UK Media]". Berlin. 2016-07-12
ImmunArray Ltd.. (7/12/16). "Press Release: Private Investment Group Leads $10 Million B Funding Round in ImmunArray". Jerusalem & Richmond, VA. 2016-07-12
Valneva S.E.. (7/12/16). "Press Release: European Investment Bank Grants Valneva a €25 Million Loan to Fund R&D Activities". Lyon & Luxembourg. 2016-07-12
Themis Bioscience GmbH. (7/12/16). "Press Release: New Worldwide, Exclusive License Agreement Provides Broad Access to Institut Pasteur's Virus Vector Technology – Zika Vaccine Development Progressing with High Priority". Vienna. 2016-07-12
Blink Biomedical S.A.S.. (7/12/16). "Press Release: Blink Biomedical Announces Close of Series A Funding". Lyon. 2016-07-12
Promethera Biosciences S.A.. (7/12/16). "Press Release: Promethera Biosciences Appoints World-class Scientific and Medical Advisory Board". Mont-Saint-Guibert. 2016-07-12
PerkinElmer, Inc.. (7/12/16). "Press Release: PerkinElmer Prices Offering of Euro-denominated Senior Notes". Waltham, MA. 2016-07-12
Vaximm AG. (7/12/16). "Press Release: Vaximm Initiates Phase 1 Translational Study in Glioblastoma with Oral T-cell Immunotherapy, VXM01". Basel & Mannheim. 2016-07-12
Cell Medica Ltd.. (7/12/16). "Press Release: Cell Medica Acquires Delenex Therapeutics". London. 2016-07-12
Merus N.V.. (7/12/16). "Press Release: Merus Announces First Quarter 2016 Financial Results and Highlights Recent Clinical Progress and Corporate Developments". Utrecht. 2016-07-12
Merus N.V.. (7/12/16). "Press Release: Merus Announces Second Quarter 2016 Financial Results and Reviews Recent Clinical Progress and Corporate Developments". Utrecht. 2016-07-12
Biomunex Pharmaceuticals SASU. (7/11/16). "Press Release: Biomunex Presents Novel Data Confirming Optimal Druglike Properties and Activity of BiXAb Antibodies". Paris. 2016-07-11
Agena Bioscience, Inc.. (7/11/16). "Press Release: David Coorey Joins Agena Bioscience to Lead Europe, Middle East, and Africa Business". San Diego, CA. 2016-07-11
Ipsen S.A.. (7/11/16). "Press Release: David Meek Appointed as Chief Executive Officer of Ipsen". Paris. 2016-07-11
Evotec AG. (7/11/16). "Press Release: Evotec Awarded Contract from Antibiotic Research UK to Begin Integrated Drug Discovery Collaboration". Hamburg. 2016-07-11
Thomson Reuters. (7/11/16). "Press Release: Thomson Reuters Announces Definitive Agreement to Sell Its Intellectual Property & Science Business to Onex and Baring Asia for $3.55 Billion". New York. 2016-07-11
F2G Ltd.. (7/11/16). "Press Release: F2G Ltd Announces the Appointment of Ralf Schmid to the Position of Chief Financial Officer". Manchester. 2016-07-11
Celyad S.A.. (7/11/16). "Press Release: Celyad Enters into License Agreement with Ono Pharmaceutical Co., Ltd. to Develop Allogeneic NKR-2 T-cell Immunotherapy". Mont-Saint-Guibert. 2016-07-11
Servier. (7/11/16). "Press Release: Sorrento and Servier Enter Into Exclusive Worldwide License and Collaboration Agreement for Development and Commercialization of Anti-PD-1 Antibody". San Diego, CA & Suresnes. 2016-07-11
Sygnis AG. (7/11/16). "Press Release: Sygnis AG Announces Global Launch of TruePrime Single Cell WGA Kit V2". Madrid & Heidelberg. 2016-07-11
Albany Molecular Research, Inc.. (7/11/16). "Press Release: AMRI Completes Acquisition of Euticals". Albany, NY. 2016-07-11
AMSilk GmbH. (7/11/16). "Press Release: AMSilk Grows with Additional Capital – Ramp-up of Biosteel Production". Planegg. 2016-07-11
University of Bath. (7/11/16). "Press Release: Spying on Chemistry in Real-time". 2016-07-11
Global Bioenergies S.A.. (7/11/16). "Press Release: Global Bioenergies, IBN-One and Aspen Enter into Partnership on Isooctane for Specialty Fuels". Èvry & Gothenburg area. 2016-07-11
BioInvent International AB. (7/8/16). "Press Release: BioInvent Enter Process Development and Manufacturing Collaboration with Alligator". Lund. 2016-07-08
Ablatus Therapeutics Ltd.. (7/8/16). "Press Release: Ablatus Therapeutics Founded to Develop and Commercialise Pioneering Cancer Treatment. Spin Out Company Raises £500k Seed Funding". Cambridge & Norwich. 2016-07-08
Omnes Capital S.A.S.. (7/8/16). "Press Release: Horama Raises €4 Million with Omnes Capital, Sham Innovation Santé and GO Capital". Paris. 2016-07-08
Biosaxony e. V.. (7/8/16). "Press Release: Biosaxony Launches Section Medical Technology". Dresden. 2016-07-08
Gilde Healthcare Partners. (7/7/16). "Press Release: Gilde Healthcare Leads USD 20 Million Financing Round of Belgian Sleep Therapy Company Nyxoah". Mont-Saint-Guibert. 2016-07-07
Selexis S.A.. (7/7/16). "Press Release: Turgut Ilaclari A.S. and Selexis SA Sign Service and Commercial Agreements to Progress Development of Biosimilar Products". Geneva. 2016-07-07
Uniqure N.V.. (7/7/16). "Press Release: Uniqure Appoints Jonathan Garen as Chief Business Officer". Amsterdam. 2016-07-07
High-Tech Gründerfonds Management GmbH. (7/7/16). "Press Release: Creathor Venture Leads a Series B Financing Round of € 5.2 Million in CryoTherapeutics". 2016-07-07
Novartis AG. (7/7/16). "Press Release: New Data Shows Sandoz Biosimilar Etanercept Candidate Has Equivalent Efficacy to Originator Product". Holzkirchen. 2016-07-07
Onxeo S.A.. (7/7/16). "Press Release: Onxeo Collaborates with the Royal College of Surgeons in Ireland for Research Program on Beleodaq Derivatives". Paris & Copenhagen. 2016-07-07
Actelion Ltd.. (7/7/16). "Press Release: Actelion to Enter Phase II Clinical Development with New Dual Orexin Receptor Antagonist in Patients with Insomnia". Allschwil. 2016-07-07
AC Immune S.A.. (7/7/16). "Press Release: AC Immune to Receive Milestone Payment for Anti-Tau Antibody Moving into Phase 1 Trial for Alzheimer’s Disease". Lausanne. 2016-07-07
Evotec AG. (7/6/16). "Press Release: Evotec Enters License Agreement for Access to CRISPR-Cas9 Gene Editing Technology". Hamburg. 2016-07-06
Genticel S.A.. (7/6/16). "Press Release: Genticel Appoints Eumedix as Strategic Advisor to Support Company’s Access to Innovative Drug Candidates". Paris & Toulouse. 2016-07-06
Scientific Laboratory Supplies Ltd. (SLS). (7/6/16). "Press Release: Analab Ltd Acquired by Scientific Laboratory Supplies in Market Growth Plan". 2016-07-06
Sartorius AG. (7/6/16). "Press Release: Sartorius Stedim Biotech Acquires U.S. Start-up kSep Systems. Transaction to Expand SSB’s Bioprocessing Product Portfolio with Innovative Single-use Centrifuges". Aubagne. 2016-07-06
Sanofi S.A.. (7/6/16). "Press Release: Sanofi Pasteur Signs Research Agreement for Zika Vaccine. Walter Reed Army Institute of Research to Transfer Technology". Paris. 2016-07-06
Actelion Ltd.. (7/6/16). "Press Release: Actelion Initiates Phase III Study to Evaluate Macitentan (Opsumit) in Children with PAH". Allschwil. 2016-07-06
bioMérieux S.A.. (7/6/16). "Press Release: bioMérieux Enlarges Its Pathogen Identification Capability on VITEK MS". Marcy l’Étoile. 2016-07-06
Numares AG. (7/6/16). "Press Release: Laboratory Group Limbach Expands Lipid Analysis with Numares Test". Regensburg. 2016-07-06
Bio-Techne Corporation. (7/6/16). "Press Release: Bio-Techne Announces Agreement to Acquire Advanced Cell Diagnostics". Minneapolis, MN. 2016-07-06
Bristol-Myers Squibb Company. (7/5/16). "Press Release: Bristol-Myers Squibb Acquires Cormorant Pharmaceuticals". New York, NY & Stockholm. 2016-07-05
Gilde Healthcare Partners. (7/5/16). "Press Release: Gilde Healthcare Participates in EUR 12.5 Million Round of Dutch Sleep Apnea Scale-up NightBalance". Delft. 2016-07-05
Scientific Laboratory Supplies Ltd. (SLS). (7/5/16). "Press Release: Dominique Dutscher (DD) and Scientific Laboratory Supplies Ltd (SLS) Join Forces to Better Serve Their Customers across Europe". Brumath & Nottingham. 2016-07-05
Biogen Inc.. (7/5/16). "Press Release: Biogen and AbbVie’s Once-Monthly Zinbryta (daclizumab) Approved in European Union for Treatment of Multiple Sclerosis". Cambridge, MA & North Chicago, IL. 2016-07-05
Bayer AG. (7/5/16). "Press Release: Innovation Needs Knowledge Exchange and Partnerships. Bayer Supports Novel Ideas to Increase Crop Productivity". Monheim. 2016-07-05
Sanofi S.A.. (7/5/16). "Press Release: Sanofi and Regeneron Announce Approval of Praluent (alirocumab) for the Treatment of Hypercholesterolemia in Japan". Paris & Tarrytown, NY. 2016-07-05
Sanofi S.A.. (7/5/16). "Press Release: Sanofi Enters into Confidentiality Agreement with Medivation and Will be Provided Due Diligence Access and Confidential Information". Paris. 2016-07-05
Nicox S.A.. (7/5/16). "Press Release: Nicox to Transfer Commercial Operations to New Pan-European Ophthalmic Specialty Pharmaceutical Company Led by GHO Capital". Sophia Antipolis. 2016-07-05
Mologen AG. (7/5/16). "Press Release: Mologen AG – Medium-term Funding from Existing Capital Authorizations Possible [Not for United States, Australia, Canada or Japan or any other jurisdiction whereunlawful]". Berlin. 2016-07-05
OSE Immunotherapeutics S.A.. (7/5/16). "Press Release: OSE Immunotherapeutics Announces Exercise of Option within Global License Agreement with Janssen for Further Clinical Development of FR104 and Potential Commercialisation in Autoimmune Diseases". Par 2016-07-05
TiGenix N.V.. (7/5/16). "Press Release: Takeda and TiGenix Enter into Licensing Agreement for Ex-U.S. Rights to Cx601 for the Treatment of Complex Perianal Fistulas in Patients with Crohn’s Disease". Osaka & Leuven. 2016-07-05
TiGenix N.V.. (7/5/16). "Press Release: TiGenix Reconfirms Its Strategic Focus on Its Allogeneic Stem Cell Platforms". Leuven. 2016-07-05
GNA Biosolutions GmbH. (7/5/16). "Press Release: GNA Biosolutions Adds CEO to Expand Its Management team". Munich. 2016-07-05
Onxeo S.A.. (7/4/16). "Press Release: Onxeo Receives USPTO Notice of Allowance for Key AsiDNA Patent, Extending IP Protection in the U.S. until 2031". Paris & Copenhagen. 2016-07-04
Global Bioenergies S.A.. (7/4/16). "Press Release: Global Bioenergies Obtains a €400,000 Grant from the German Federal Ministry of Research and Education (BMBF) to Produce Renewable Gasoline Additives – Audi Will Use These for Engine Testing". Leuna. 2016-07-04
Zedira GmbH. (7/1/16). "Press Release: Dr. Falk Pharma GmbH and Zedira Enter a Phase 1b Clinical Trial for a Celiac Disease Drug". Freiburg & Darmstadt. 2016-07-01
bioMérieux S.A.. (7/1/16). "Press Release: bioMérieux Receives FDA Clearance for Expanded Use of VIDAS B•R•A•H•M•S PCT Test for Managing Sepsis Patients with Elevated Risk of Mortality". Marcy l’Étoile. 2016-07-01
next pagenext page 1 2 3 ... 80 81 82  next pagenext page


Picture [iito] Made Without Love 650x80px

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to and simply fill the subject line with the word »LSE Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]


Picture Berlin Partner Network in German Capital Region 650x80px

» top